(3R,4S)-4-(3,4-Dimethoxyphenyl)Pyrrolidine-3-Carboxylic Acid

Manufacturing-scale deployment of (3R,4S)-4-(3,4-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid across current Good Manufacturing Practice (cGMP) pharmaceutical intermediate supply chains has revealed sharply divergent purity thresholds and processing behaviors depending on the target chiral resolution pathway. A single recrystallization from isopropanol/water (7:3 v/v) typically yields material assaying at ≥99.0% chiral purity by HPLC (Chiralpak IA column, 250 × 4.6 mm, hexane/ethanol/0.1% trifluoroacetic acid, 1.0 mL/min, 254 nm), which proves adequate for peptide coupling sequences where the pyrrolidine nitrogen undergoes subsequent Boc protection. However, lyophilization of the final hydrochloride salt on a Virtis Genesis 35L shelf lyophilizer exposes a recurring batch failure mode: residual acetic acid from the deprotection step forms a low-melting eutectic with the dihydrate polymorph, collapsing the cake structure at shelf temperatures exceeding −25 °C. Plant engineers addressing this bottleneck have successfully implemented a modified cycle with an extended secondary drying ramp of 48 hours at −30 °C under 50 mTorr, followed by atmospheric restoration with dry nitrogen (dew point ≤ −70 °C) to suppress deliquescence of the amorphous fraction.

At What Stoichiometric Ratio Does Epimerization at C-3 Compromise Diastereomeric Excess in Amide Bond Formation?

Coupling of (3R,4S)-4-(3,4-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid to amino acid esters via TBTU/HOBt activation in DMF reveals a pH-dependent epimerization pathway that erodes diastereomeric excess (de) when the transient mixed anhydride intermediate remains unquenched for dwell times exceeding 90 seconds at 0–5 °C. In situ ReactIR monitoring (Mettler Toledo ReactIR 15, DiComp probe) of the carboxylate stretching region (1600–1650 cm⁻¹) confirms that complete consumption of the starting acid requires a minimum of 1.05 equivalents of the coupling reagent relative to the nucleophilic amine component. Production batches executed on a 100 L glass-lined reactor with retreat-curve impeller agitation at 120 rpm consistently achieve isolated yields of 82–87% with de ≥98.5% when the pre-activation step is limited to 45 seconds and the amine hydrochloride is introduced as a single portion in DMF containing 2.1 equivalents of N-methylmorpholine. The relevant quality standard is anchored in ICH Q3C(R8) residual solvent limits, with DMF controlled to ≤880 ppm in the dried intermediate and acetonitrile (used in subsequent trituration) to ≤410 ppm. This chiral pyrrolidine acid functions as the stereodefining fragment in the convergent synthesis of dipeptidyl peptidase-4 (DPP-4) inhibitor candidates, where the terminal product isolated after silica gel chromatography (ethyl acetate/methanol/9:1, Rf 0.35) is a crystalline amide derivative with a melting range of 168–171 °C (DSC, 10 °C/min, nitrogen purge).

Pyrrolidine Scaffold Immobilization onto Aminopropyl Silica: Column Packing Protocols and Dynamic Binding Capacity

Preparation of a cinchona alkaloid-inspired chiral stationary phase (CSP) by covalent anchoring of the (3R,4S)-configured pyrrolidine acid to 3-aminopropyl-functionalized silica gel (particle size 5 μm, pore diameter 100 Å, surface coverage 3.2 μmol/m²) proceeds via a carbodiimide-mediated amidation. The slurry reaction, conducted in anhydrous toluene at 80 °C for 18 hours, incorporates the acid at a loading of 0.8 mmol per gram of derivatized silica, representing a 25% stoichiometric excess relative to accessible amine sites calculated from BET surface area (320 m²/g). Post-reaction elemental analysis (C, H, N) of the washed and vacuum-dried CSP indicates a ligand surface density of 0.42 μmol/m², corresponding to approximately 55% reaction efficiency at the solid–liquid interface—a value consistent with the steric shielding imposed by the 3,4-dimethoxyphenyl substituent. Axial compression of the resulting CSP into a 250 × 4.6 mm i.d. stainless steel column (packing pressure 450 bar, slurry medium chloroform/methanol 1:1) yields a reduced plate height of 2.8–3.2 for trans-stilbene oxide enantiomers under reversed-phase conditions (acetonitrile/water 40:60, 1.0 mL/min). The critical operational limit emerges at mobile phase pH >7.5, where gradual hydrolysis of the amide tether releases the pyrrolidine acid into the eluent, detected as a steadily increasing background absorbance at 280 nm after 2000 column volumes. Regulatory qualification of this CSP for analytical method validation follows ICH Q2(R2) guidelines, with resolution factor (Rs) between the target enantiomer pair maintained at ≥2.0 throughout the column lifetime specification of 3000 injections.

Incorporating (3R,4S)-4-(3,4-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid at 4.0 mol% relative to a transient N-sulfonyl imine electrophile in an asymmetric organocatalytic Mannich reaction (toluene, −20 °C, 72 hours) generates β-amino carbonyl adducts with enantiomeric excesses reliably measured at 91–94% by chiral supercritical fluid chromatography (SFC, Chiralcel OD-H, CO₂/methanol/85:15, 3.0 mL/min, backpressure 150 bar). The pyrrolidine nitrogen functions as a nucleophilic catalyst that engages the imine substrate via reversible iminium ion formation, with the rigid (3R,4S)-configuration directing electrophilic attack to the less hindered face. In a pilot-plant campaign utilizing a 50 L Hastelloy reactor equipped with a HET-4 hollow-shaft agitator, the exothermic quenching step with saturated ammonium chloride necessitated a controlled addition rate of 0.8 L/min to maintain internal temperature below 5 °C; batch thermal runaway was recorded during one deviation event when the addition rate briefly exceeded 2.1 L/min, causing localized acidification that promoted N-protonation and uncatalyzed background reaction, reducing ee to 73%. The finished small molecule target, produced after reductive amination and tartrate salt resolution, is an NK₁ receptor antagonist candidate whose hydrochloride monohydrate polymorph exhibits characteristic XRD reflections at 2θ values of 8.7°, 14.3°, and 21.5° (Cu Kα radiation).

Table 1. Comparative Lot Release Data for Two Synthetic Lineages of the Intermediate

A distinct processing window emerges when the (3R,4S)-pyrrolidine acid is deployed as a ligand precursor for copper(II)-catalyzed asymmetric Henry reactions. In this protocol, the acid undergoes in situ complexation with Cu(OAc)₂·H₂O (5 mol%) in ethanol at 25 °C for 30 minutes before nitromethane and the aldehyde substrate are sequentially introduced. The resulting chiral copper complex, believed to adopt a distorted square-planar geometry based on UV-Vis absorption at 680 nm with a molar extinction coefficient of approximately 120 M⁻¹cm⁻¹, catalyzes the condensation of 4-nitrobenzaldehyde and nitromethane to furnish (R)-nitroaldol product in 88% yield and 84% ee after 6 hours at 0 °C. Production personnel report that the catalyst activity diminishes sharply when the reaction solvent contains >0.5% water, attributable to competitive hydration of the Cu(II) center and displacement of the pyrrolidine acid ligand. Therefore, the ethanol must be dried over 3Å molecular sieves to a Karl Fischer endpoint of ≤0.01% water before use, and the reactor headspace must be continuously purged with dry nitrogen. The downstream processing sequence comprises filtration through a pad of Celite 545 (pre-wetted with anhydrous ethanol), concentration on a rotary evaporator with bath temperature not exceeding 35 °C, and flash chromatography (silica gel 60, 230–400 mesh, hexane/ethyl acetate gradient). The β-nitro alcohol product is then reduced with Raney nickel under hydrogen (40 psi) in methanol to yield the corresponding 1,2-amino alcohol, which serves as a penultimate intermediate toward (S)-norephedrine-derived pharmaceuticals requiring ICH M7-compliant control of the (3R,4S)-pyrrolidine acid at the toxicology threshold of concern (TTC) of 1.5 μg/day.

Table 2. ICH and Pharmacopoeial Quality Attributes Applied to the Chiral Pyrrolidine Acid Intermediate

Investigation into the solid-state stability profile of the zwitterionic form of (3R,4S)-4-(3,4-Dimethoxyphenyl)pyrrolidine-3-carboxylic acid under accelerated storage conditions (40 °C/75% RH, open dish in a Binder KBF 720 constant climate chamber) reveals a polymorphic transformation beginning at 72 hours of exposure. Powder X-ray diffractometry of the initial crystalline material matches the reference pattern for the anhydrous Form I (characteristic peaks at 2θ: 9.2°, 13.8°, 17.5°, 22.1°), while the partially converted sample after 120 hours displays new reflections consistent with a monohydrate phase (additional peaks at 2θ: 11.4°, 20.6°, 25.9°), accompanied by a 1.2% w/w increase in water content. This conversion is completely reversible upon drying in a vacuum oven at 50 °C and 10 mbar for 8 hours, yet the cycled material presents a broader particle size distribution (spread increasing from a D90/D10 ratio of 3.8 to 7.1 as measured by laser diffraction on a Malvern Mastersizer 3000) that adversely affects flowability through a rotary tablet press feed frame. Consequently, the intermediate must be stored in heat-sealed, nitrogen-flushed aluminum foil laminate bags containing silica gel desiccant canisters that maintain internal RH <15% throughout the labeled retest period of 24 months from the date of manufacture. In regulated peptide production suites operating under EU GMP Annex 1 classification for aseptic processing, the acid is weighed in a Grade C environment before transfer to the synthesis suite via a pass-through airlock, with all open handling completed within a maximum allowable exposure time of 15 minutes to limit moisture uptake.

When the Dimethoxyphenyl Substituent Dictates Conformational Locking in Peptidomimetic β-Turn Mimics

Solution-phase 1H NMR (Bruker Avance NEO 600 MHz, DMSO-d₆, 25 °C) and X-ray crystallographic analysis of the N-acetyl amide derivative of (3R,4S)-4-(3,4-dimethoxyphenyl)pyrrolidine-3-carboxylic acid confirm a strong preference for a trans amide geometry (rotamer population ≥95% at 298 K, coalescence temperature 342 K) that enforces a dihedral angle φ of approximately −65° and ψ of 140° at the pyrrolidine C-3/C-4 junction. This conformational pre-organization substantially reduces the entropic penalty associated with β-turn nucleation when the scaffold is inserted into a growing peptide chain on solid support. In an Fmoc-strategy microwave-assisted peptide synthesis (CEM Liberty Blue, 90 °C, 5 minutes coupling, HBTU/DIPEA activation), the sterically hindered secondary amine of the pyrrolidine ring requires double coupling cycles to achieve Kaiser test-negative completion; the recommended protocol delivers 3.0 equivalents of the N-Fmoc-protected pyrrolidine acid derivative, 3.0 equivalents of HBTU, and 6.0 equivalents of DIPEA in DMF, with a second identical coupling executed after a 1-minute DMF wash. Published data for this specific configuration on Wang resin (loading 0.3 mmol/g) indicate a final crude peptide purity of 72% by reversed-phase HPLC (C18, 5–95% acetonitrile in water with 0.1% TFA over 20 minutes), with the major impurity identified by LC-MS as the deletion sequence missing the pyrrolidine residue. The target class of molecules comprises macrocyclic peptidomimetics designed to inhibit protein–protein interactions at the MDM2/p53 binding interface, where the dimethoxyphenyl group occupies a complementary hydrophobic pocket adjacent to the Trp23 indole-recognition cleft.